143 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Baxalta Investments

Baxalta has invested in 2 companies and its latest investment was OncoResponse on May 25, 2016

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

OncoResponse is a Washington-based biotechnology company that researches and develops immunotherapies for the treatment of cancer.
$3M
May 25, 2016
-
True North is a biotechnology company that engages in research and development of humanized antibodies and novel therapies to treat rare diseases.
$40M
Dec 02, 2015
May 01, 2017

Frequently Asked Questions about Baxalta

  1. What is Baxalta investing in?

    Baxalta has invested in 2 companies including OncoResponse and True North Therapeutics

  2. What company did Baxalta invest in?

    Baxalta invested in a total 2 companies including OncoResponse and True North Therapeutics

  1. What are the top 2 investments by Baxalta?

    The top companies in which Baxalta invested are OncoResponse and True North Therapeutics